-- 据周一台湾交易所发布的消息，Applied BioCode（股票代码：TPE:6598）的美国子公司已获得美国FDA的510(k)许可，其呼吸道病原体检测板获批上市。 此次获批允许该检测板与BioCode MDx 3000系统以及赛默飞世尔科技的KingFisher萃取平台配合使用，进一步扩展了其与生物梅里埃和罗氏系统的兼容性。 该公司表示，此次获批使其能够在美国销售该组合解决方案，为实验室提供更灵活的萃取系统选择，并有望提升其业务和财务业绩。
Related Articles
Asia
Market Chatter: Coles CEO Says Grocery Price Increases 'Inevitable' Amid Fuel Cost Surge
Coles Group (ASX:COL) Chief Executive Leah Weckert said price hikes for groceries are "inevitable" as the supermarket chain and its suppliers deal with higher fuel costs, Bloomberg reported Monday.Speaking at an Australian Shareholders' Association conference in Melbourne, Weckert said that the trend is showing up in supermarket data, with shoppers opting for beef mince or chicken over steak, while also making fewer trips to stores to cut fuel costs.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$ASX:COL
Asia
Singapore Airlines to Deploy Starlink Broadband Services in 2027
Singapore Airlines (SGX:C6L) will deploy Starlink's low-earth-orbit satellite-based broadband service on its planes, starting from the first quarter of 2027, according to a company release on Monday.The service will be available to all cabin classes on Starlink-enabled aircraft.
$SGX:C6L
Asia
iX Biopharma Secures Listing and Quotation Notice for New Shares; Shares Zoom 11%
iX Biopharma (SGX:42C) received a listing and quotation notice from the Singapore Exchange Securities Trading for 1.3 million shares, according to a Thursday filing with the Singapore Exchange.Shares of the pharmaceutical and nutraceutical company surged nearly 11% in Monday trading.The notice is subject to shareholder approval and compliance with the bourse's listing requirements, the filing added.
$SGX:42C